Study guide

14.1 Gastrointestinal Procedures

Certified Nuclear Medicine Technologist CNMT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CNMT Exam Facts 1.2 How to Use This Guide

2 Radiation Physics Fundamentals

2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles

3 Biological Effects & ALARA

3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring

4 NRC & Regulatory Compliance

4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records

5 Generators & Kit Preparation

5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control

6 Tc-99m Diagnostic Agents

6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells

7 Non-Tc Diagnostic & PET Agents

7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents

8 Therapeutics, Adjuncts & Administration

8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents

9 Non-Imaging Instrumentation

9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment

10 Imaging Systems & Quality Control

10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization

11 Pulmonary, Bone, Oncology & Infection Imaging

11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures

12 Renal, Endocrine & Hematopoietic Imaging

12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

13 Cardiovascular Procedures

13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing

14 GI, CNS, Therapy & Hybrid CT Procedures

14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency

15 Patient Care & Clinical Workflow

15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis

14.1 Gastrointestinal Procedures

Key Takeaways Explain This Topic AI

Gastric emptying uses standardized solid (egg-white sandwich) and/or liquid meals with geometric-mean anterior–posterior imaging at fixed times (classically 0, 1, 2, 3, 4 h solid)

GE reflux imaging and liquid emptying protocols differ from solid solid-meal SOP—know meal type, positioning, and reflux markers when ordered

GI bleeding scintigraphy with Tc-99m labeled RBCs localizes active bleeding; hemangioma studies use labeled RBCs with delayed SPECT/SPECT-CT blood-pool pattern

Hepatobiliary (mebrofenin/disofenin) evaluates cystic duct patency and biliary kinetics; morphine contracts the sphincter of Oddi to fill the gallbladder; CCK (sincalide) measures GBEF

Liver–lung shunt mapping uses arterial MAA for Y-90 planning; liver–spleen colloid maps RES; Meckel’s diverticulum uses Tc-99m pertechnetate for ectopic gastric mucosa

Last updated: August 2026

14.1 Gastrointestinal Procedures

Quick Answer: Gastric emptying = standardized solid/liquid meal + geometric mean timed images. Labeled RBCs = GI bleed and hemangioma. Mebrofenin ± morphine/CCK = biliary tree and GBEF . Arterial MAA = Y-90 liver–lung shunt. Colloid = liver–spleen. Pertechnetate = Meckel’s. Prep, timing, and QC decide whether the study is diagnostic.

Domain V GI items reward protocol fidelity : correct meal, times, adjunct drug, and standard processing—not free-form “looks empty enough.”

  • Gastric Emptying (Solid and Liquid)
  • Solid meal (standard teaching)

Society-standardized solid gastric emptying uses a low-fat egg-white sandwich meal (toast/jam/water per protocol) labeled with Tc-99m sulfur colloid cooked into the egg whites. Adult activity is typically ~0.5–1 mCi class in the meal. The patient must finish in a defined window (often ≤10 min); incomplete intake is documented and may invalidate reference ranges.

  • Time point (solid, common) Action
  • 0 h Immediate post-meal anterior + posterior (or dual-head) images
  • 1, 2, 3, 4 h Same geometry; report percent retained (or emptied)
  • Processing Geometric mean of anterior and posterior stomach counts ± decay correction

Geometric mean (√[Ant × Post]) reduces depth-dependent error as the meal moves in the abdomen. Draw a careful stomach ROI; exclude small-bowel activity already emptied. Delayed emptying = high residual at late times (protocol-specific cutoffs).

Liquid emptying and GE reflux

Liquid studies (Tc-99m sulfur colloid or DTPA in water/juice) empty faster; imaging intervals are minutes, not hours. Gastroesophageal reflux protocols image esophagus/stomach after a liquid or semi-solid meal, sometimes with binder or maneuvers per SOP. Do not apply solid reference ranges to liquid curves.

Prep traps: prokinetics or narcotics alter emptying; follow NPO orders; vomiting ruins quantification; motion and inconsistent camera distance bias counts.

GI Bleeding Scintigraphy (Tc-99m Labeled RBCs)

In vitro (preferred) or modified in vivo Tc-99m RBC labeling produces a blood-pool tracer that extravasates at active lower (and some upper) GI bleeds. Adult activity ~20–30 mCi class IV. Acquire flow if ordered, then sequential statics or continuous dynamic imaging for hours; delays catch intermittent bleeds.

  • Tech priority Why
  • Labeling efficiency QC Free Tc → stomach/thyroid/kidneys mimics or masks bleed
  • Continuous/serial imaging Intermittent bleeding is missed on sparse snapshots
  • Anatomic landmarks Mark iliac crests; cover upper and lower abdomen as ordered
  • SPECT/CT when available Localizes extravasation for surgery/angiography

Positive teaching pattern: activity that appears, intensifies, and moves in a bowel pattern. Fixed vascular structures (aorta, bladder blood pool) are not luminal bleeds.

Hepatic Hemangioma (Labeled RBC SPECT)

Same Tc-99m labeled RBCs , different question. Early flow may be photopenic; delayed blood-pool planar + SPECT/SPECT-CT (often 1–2 h) shows progressive fill-in greater than surrounding liver—classic cavernous hemangioma. Confirm labeling QC; small lesions may be below SPECT resolution.

Hepatobiliary Imaging ± GBEF

Tc-99m mebrofenin (or disofenin) is extracted by hepatocytes and excreted into bile. Fast 2–6 h (not multi-day starvation that collapses the gallbladder). Adult activity often ~3–5+ mCi IV (higher if bilirubin elevated—protocol).

Finding / maneuver Teaching meaning

Gallbladder visualization Cystic duct patent (supports against complete cystic-duct obstruction pattern when criteria met)

  • Nonvisualization of GB Suggests cystic duct obstruction if liver and bowel activity appear on time
  • Morphine sulfate Contracts sphincter of Oddi → raises biliary pressure → fills GB if cystic duct open
  • CCK / sincalide Stimulates GB contraction; GBEF = (max − min)/max × 100% after infusion

Give morphine only when ordered after protocol criteria (e.g., bowel seen, GB still absent). CCK infusion rate matters—too rapid causes spasm and invalid EF. Document last meal, opioids, and TPN. Your job for dyskinesia studies: correct infusion timing, GB ROI (not bowel), complete dynamics.

Liver–Lung Shunt Mapping (Arterial MAA for Y-90)

Before Y-90 microspheres , IR injects Tc-99m MAA into the planned hepatic artery territory. Image liver and lungs (planar ± SPECT/CT). Lung shunt fraction = lung / (lung + liver) counts (SOP geometry). High shunt may reduce or contraindicate Y-90 activity. Coordinate IR timing, assay MAA, image promptly, avoid free-Tc misread as shunt, and flag extrahepatic nontarget foci.

Liver–Spleen Imaging

Tc-99m sulfur colloid (IV, ~4–6 mCi adult class) is phagocytosed by Kupffer cells and splenic/RES marrow. Planar and SPECT/SPECT-CT map hepatomegaly, colloid shift, defects, and splenules. Do not confuse colloid defects with hemangioma blood-pool fill-in—different agents.

Meckel’s Diverticulum

Tc-99m pertechnetate concentrates in gastric mucosa , including ectopic mucosa in a Meckel’s (usually RLQ). Weight-based activity (~5–10 mCi adult class). NPO; optional H2 blockade per protocol. Dynamic abdomen ~30–60 min. Positive: focus appearing with the stomach, usually RLQ. Traps: ureter/bladder activity, recent barium, active bleeding.

GI Procedure Comparison

  • Study Agent Core tech focus
  • Solid GE Tc-99m SC in egg meal Standard meal, 0–4 h, geometric mean
  • GI bleed Tc-99m RBCs Label QC, serial imaging, moving focus
  • Hemangioma Tc-99m RBCs Delayed SPECT blood-pool fill-in
  • HIDA ± GBEF Mebrofenin ± morphine/CCK Fasting window, adjunct timing, GB ROI
  • Y-90 planning Arterial MAA Lung shunt fraction, nontarget foci
  • Liver–spleen Sulfur colloid RES map, colloid shift
  • Meckel’s Pertechnetate Ectopic gastric mucosa focus

Bottom line: GI nuclear medicine is meal standards, blood-pool labeling, biliary pharmacology, and arterial coordination —execute the protocol, then process with geometric means and honest ROIs.